MALVERN, Pa., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced that Mel Sorensen, M.D., President and Chief Executive Officer, will participate in a fireside chat as part of the Piper Sandler 32nd Annual Virtual Healthcare Conference, being held December 1-3, 2020.
See the article here:
Galera Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
- 001 Eton Pharmaceuticals Announces Closing of Public Offering [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 002 Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 003 Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for Relapsed or Refractory IDH1-mutant Acute... [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 004 Stabilization measures taken [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 005 Coherus BioSciences Announces New Employment Inducement Grants [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 006 Biomerica Reports Fiscal 2021 1st Quarter Financial Results [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 007 Y-mAbs Announces Update on Naxitamab and Omburtamab in Neuroblastoma [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 008 German Federal Joint Committee (G-BA) Issues Nationwide Reimbursement Decision for EndoPredict® Breast Cancer Prognostic Test [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 009 SPACs Show Investors Faster, Simpler Way to Go Public [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 010 Psychedelics Experiencing Renaissance, Offer Tremendous Treatment Potential [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 011 Spero Therapeutics to Present Data for All Pipeline Programs at IDWeek 2020 [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 012 Zogenix Receives Positive CHMP Opinion for FINTEPLA® (Fenfluramine) Oral Solution for the Treatment of Seizures in Patients with Dravet Syndrome [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 013 Beyond Air® Presents Positive New Preclinical Data for the Use of a Single Injection of Gaseous Nitric Oxide as a Novel In situ Cancer Vaccination [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 014 CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 015 Novartis receives positive CHMP opinion for Leqvio®* (inclisiran), a potential first-in-class siRNA for the treatment of high cholesterol [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 016 Aimmune Receives Positive CHMP Opinion on PALFORZIA® for the Treatment of Patients with Peanut Allergy in Europe [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 017 Theratechnologies Appoints Two New Board Members [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 018 Nephros Announces Pricing of $5 Million Registered Direct Offering of Common Stock [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 019 First Patient Dosed in Phase II Trial to Treat Complications in COVID-19 [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 020 Cantor Fitzgerald and Kristen Kluska to Host Zoom Fireside Chat with Ocugen [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 021 Tauriga Sciences, Inc. Updates Shareholders on New York State's Determination to Allow the Sale of CBD Edibles in the Forms of Food & Drink [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 022 Zenith Confirms Interim Filings on SEDAR [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 023 Trading by management and close relations of management [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 024 AXIM® Biotechnologies Issues Update Letter to Shareholders [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 025 One World’s Dr. Kenneth Perego Joins Montel Williams for Blunt Discussion [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 026 Yield10 Bioscience Announces Start of Field Tests of Winter Camelina Varieties [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 027 Pandion Therapeutics Highlights Potential of Modular Biologics Pipeline for the Treatment of Autoimmune Diseases at FOCIS 2020 [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 028 Scout Bio Advances Novel Gene Therapy for the Treatment of Feline Diabetes [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 029 Rhythm Pharmaceuticals Appoints Jennifer Chien as Executive Vice President, Head of North America [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 030 Kane Biotech builds upon successful results with launch of a US Consumer Test [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 031 VYNE Therapeutics to Report Third Quarter 2020 Financial Results on November 5th [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 032 CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 033 BetterLife Provides Important Update on its Australian Clinical Study Design [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 034 Iovance Biotherapeutics to Present at Upcoming Conferences in November [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 035 Otonomy to Report Third Quarter 2020 Financial Results and Provide Corporate Update [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 036 OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 037 Verona Pharma plc : Update on AIM Delisting [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 038 Kraig Biocraft Laboratories Delivers Recombinant Spider Silk Silkworm Eggs to Production Facility in Vietnam [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 039 G1 Therapeutics to Provide Third Quarter 2020 Corporate and Financial Update on November 4, 2020 [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 040 MediPharm Labs Sets Date to Release Third Quarter 2020 Financial Results [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 041 MediciNova Announces Presentation of Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model at The Liver Meeting Digital Experience™... [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 042 Aileron Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 043 PLx Pharma Inc. 2020 Third Quarter Financial Results and Business Update Conference Call Rescheduled to November 16, 2020 [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 044 Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2020 Financial Results [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 045 Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate Update [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 046 EXMceuticals Provides Bi-Weekly Default Status Report [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 047 T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 048 Tonix Pharmaceuticals Outlines New Statistical Method to Analyze Future PTSD Studies at the 3rd Annual Neuropsychiatric Drug Development Summit [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 049 Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 050 ERYTECH to Present at Jefferies Virtual Healthcare Conference [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 051 Osmotica Pharmaceuticals plc to Present at 2020 Jefferies Virtual London Healthcare Conference [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 052 Harpoon Therapeutics Presents Encouraging Preclinical Data for HPN601 EpCAM ProTriTAC™ Program at 35th SITC Annual Meeting [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 053 Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 054 Ovid Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 055 Berkeley Lights Reports Financial Results for Third Quarter of Fiscal Year 2020 [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 056 Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 057 Annexon Expands Classical Complement Platform into Neurodegenerative Diseases of the Brain with Initiation of Huntington’s Disease Clinical Program [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 058 ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2020 [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 059 Neuronetics to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 060 Retrophin Completes Acquisition of Orphan Technologies [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 061 Resverlogix Files Notice of Annual and Special Meeting of Shareholders [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 062 Zenith Files Notice of Annual and Special Meeting of Shareholders [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 063 LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 064 Chalice Farms to Launch “Holiday in Color” Pre-Roll Packs, Festive Promotions through Holiday Season [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 065 Auris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 066 Timber Pharmaceuticals Signs Waiver Agreement with Warrant Holders [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 067 BioDelivery Sciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 068 Chiasma to Host an Expert Panel on Acromegaly and the MPOWERED® Phase 3 Trial Results [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 069 Praxis Precision Medicines to Participate in Upcoming Investor Conferences [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 070 Aditxt Appoints Anthony Voorhies as Head of Business Development for AditxtScore™ [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 071 Black Diamond Therapeutics Provides Update on GBM Program and Presents Pre-Clinical Data at the 2020 SNO Annual Meeting [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 072 Todos Medical Announces Positive In Vitro Data for Tollovid™ Confirming 3CL Protease Inhibition Mechanism of Action [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 073 Harrow Health Announces Participation at the Piper Sandler 32nd Annual Healthcare Conference [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 074 New Test for Triaging Preeclampsia Passes Key Development Milestone: Progenity Releases Prospective Clinical Verification Data for its Preecludia™... [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 075 Adaptimmune to Showcase Market Potential for SPEAR T-cell Portfolio and Pipeline with Multiple Cell Therapy Platforms During Virtual Investor Day [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 076 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 077 Trevena, Inc. Announces Publication Highlighting GI Tolerability Profile of OLINVYK™ (oliceridine) injection in Pain and Therapy [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 078 BioRestorative Therapies Emerges from Chapter 11 Reorganization [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 079 BioCryst to Present at Upcoming Virtual Investment Conferences [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 080 GW Pharmaceuticals to Present at the Evercore ISI 2020 Healthcare Conference [Last Updated On: November 30th, 2020] [Originally Added On: November 30th, 2020]